Ctrl

K

Ozanimod

Class
Anti-inflammatory agents
Subclass
Sphingosine 1-phosphate receptor modulators
Generic name
Ozanimod hydrochloride
Brand names
Zeposia®
Common formulations
Capsule
Dosage and administration
Adults patients
Multiple sclerosis • Relapsing-remitting disease, secondary progressive
•
0.23-0.92 mg PO daily
Ulcerative colitis • Moderately active or severe
•
0.23-0.92 mg PO daily
Indications for use
Labeled indications
Adults
•
Treatment of multiple sclerosis (relapsing-remitting disease, secondary progressive)
•
Treatment of ulcerative colitis (moderately active or severe)
Interactions
Drug(s)
Check Interactions
Reset

What did you think about this content?

Create free account

Sign up for free to access the full drug resource